Serological Assays for the Detection and Characterization of Influenza Viruses
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | Georgia |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Posted Date: | Jan 16, 2025 |
| Due Date: | Feb 7, 2025 |
| Solicitation No: | 75D30125R73235 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Solicitation (Original)
- Original Published Date: Jan 16, 2025 05:46 pm EST
- Original Date Offers Due: Feb 07, 2025 02:00 pm EST
- Inactive Policy: Manual
- Original Inactive Date: May 15, 2025
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: Q301 - REFERENCE LABORATORY TESTING
-
NAICS Code:
- 325413 - In-Vitro Diagnostic Substance Manufacturing
-
Place of Performance:
Atlanta , GAUSA
The objective of this contract is to support the Influenza Division through the testing of human sera via hemagglutination inhibition assay as well as develop a new serology platform that is comparable to hemagglutination inhibition assay.
This is Phase I of a a two phased multi-step mandatory down select solicitation. Interest for Phase I is due to the contracting officer no later than 2:00 PM EST February 7, 2025.
The steps in Phase I are as follows:
-
- Letter of Interest – offerors shall email POC information to Contracting Officer
- Proficiency panel will be sent by CDC to intersted offerors
- Vendor shall email results to CDC Contracting Officer
- CDC Contractng Officer will notify each offeror of their pass/fail status for Phase I and if they are then able to proceed to Phase II
- 1600 CLIFTON ROAD
- ATLANTA , GA 30333
- USA
- Jennifer Gartzke
- jgartzke@cdc.gov
- Phone Number 4044980020
- Jan 16, 2025 05:46 pm ESTSolicitation (Original)
Related Document
| Feb 19, 2025 | [Solicitation (Updated)] Serological Assays for the Detection and Characterization of Influenza Viruses |
| Mar 18, 2025 | [Solicitation (Updated)] Serological Assays for the Detection and Characterization of Influenza Viruses |
| Mar 27, 2025 | [Solicitation (Updated)] Serological Assays for the Detection and Characterization of Influenza Viruses |
| Apr 15, 2025 | [Solicitation (Updated)] Serological Assays for the Detection and Characterization of Influenza Viruses |
| Dec 11, 2025 | [Solicitation (Updated)] Serological Assays for the Detection and Characterization of Influenza Viruses |
See Also
Event ID Event Title Government Entity Start Date (ET) End Date (ET) PE-66096-NONST-2026-000000203
State Government of Georgia
Due by 10/06/2026
Event ID Event Title Government Entity Start Date (ET) End Date (ET) PE-72555-NONST-2027-000000011
State Government of Georgia
Due by 10/15/2026
Event ID Event Title Government Entity Start Date (ET) End Date (ET) PE-77081-NONST-2027-000000011
State Government of Georgia
Due by 10/23/2026
Follow NOTICE OF INTENT TO SOLE SOURCE REQUIREMENT - URGENT TELERADIOLOGY Active Contract
VETERANS AFFAIRS, DEPARTMENT OF
Due by 10/14/2026